Cargando…

Vasodilator-stimulated phosphoprotein-guided Clopidogrel maintenance therapy reduces cardiovascular events in atrial fibrillation patients requiring anticoagulation therapy and scheduled for percutaneous coronary intervention: a prospective cohort study

BACKGROUND: In a previous study, we found that titrating clopidogrel maintenance doses (MDs) according to vasodilator-stimulated phosphoprotein (VASP) monitoring minimised the rate of major adverse cardiovascular and cerebral events (MACCE) after percutaneous coronary intervention (PCI) without incr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Chaoyue, Zhang, Xumin, Liu, Yonghua, Gao, Yang, Zhao, Xiaohong, Zhou, Hua, Luo, Yu, Liu, Yaling, Wang, Xiaodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006722/ https://www.ncbi.nlm.nih.gov/pubmed/29914380 http://dx.doi.org/10.1186/s12872-018-0853-x

Ejemplares similares

Assessment of P2Y(12) Inhibition by Clopidogrel in Feline Platelets Using Flow Cytometry Quantification of Vasodilator-Stimulated Phosphoprotein Phosphorylation
por: Li, Ronald H. L., et al.
Publicado: (2020)

Modified ticagrelor loading doses according to the vasodilator-stimulated phosphoprotein phosphorylation index improve the clinical outcome in ST-elevation myocardial infarction patients with high on-treatment platelet reactivity
por: Liu, Yaling, et al.
Publicado: (2023)

Dual Antithrombotic Therapy with Clopidogrel and Novel Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Real-world Study
por: Kebernik, Julia, et al.
Publicado: (2018)

Vasodilator-Stimulated Phosphoprotein: Regulators of Adipokines Resistin and Phenotype Conversion of Epicardial Adipocytes
por: Wang, Jing, et al.
Publicado: (2018)

Vasodilator-Stimulated Phosphoprotein Biomarkers Are Associated with Invasion and Metastasis in Colorectal Cancer
por: Pitari, Giovanni M, et al.
Publicado: (2018)

Role of vasodilator-stimulated phosphoprotein in human cytomegalovirus-induced hyperpermeability of human endothelial cells
por: Tian, Yihao, et al.
Publicado: (2018)

Phosphorylation of Vasodilator-Stimulated Phosphoprotein (VASP) Dampens Hepatic Ischemia-Reperfusion Injury
por: Köhler, David, et al.
Publicado: (2011)

Vasodilator-Stimulated Phosphoprotein Activity Is Required for Coxiella burnetii Growth in Human Macrophages
por: Colonne, Punsiri M., et al.
Publicado: (2016)

The role of vasodilator-stimulated phosphoprotein (VASP) in the control of hepatic gluconeogenic gene expression
por: Tateya, Sanshiro, et al.
Publicado: (2019)

Adjunctive Cilostazol versus High Maintenance Dose of Clopidogrel in Patients with Hyporesponsiveness to Chronic Clopidogrel Therapy
por: Lee, Ga Yeon, et al.
Publicado: (2013)

"Influence of methadone on clopidogrel in addicts on methadone maintenance therapy" Drug interaction between methadone and clopidogrel
por: Fallah, Ferigol, et al.
Publicado: (2016)

High-Maintenance-Dose Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
por: Chen, Yu, et al.
Publicado: (2013)

Vasodilator Therapy: Nitrates and Nicorandil
por: Tarkin, Jason M., et al.
Publicado: (2016)

Comparison of short-term clinical outcomes between low-dose prasugrel and clopidogrel as part of triple antithrombotic therapy in patients requiring oral anticoagulant therapy and percutaneous coronary intervention
por: Kitahara, Hideki, et al.
Publicado: (2022)

Phosphorylated vasodilator-stimulated phosphoprotein (P-VASP(Ser239)) in platelets is increased by nitrite and partially deoxygenated erythrocytes
por: Srihirun, Sirada, et al.
Publicado: (2018)

Triple anticoagulation therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention – real life assessment
por: Bogacki, Paweł, et al.
Publicado: (2016)

Correction: Comparison of short-term clinical outcomes between low-dose prasugrel and clopidogrel as part of triple antithrombotic therapy in patients requiring oral anticoagulant therapy and percutaneous coronary intervention
por: Kitahara, Hideki, et al.
Publicado: (2023)

Anticoagulant Therapy for Frail Patients with Atrial Fibrillation
por: Hori, Hiroshi, et al.
Publicado: (2021)

Secondary Precipitants of Atrial Fibrillation and Anticoagulation Therapy
por: Ko, Darae, et al.
Publicado: (2021)

Erratum to: Vasodilator Therapy: Nitrates and Nicorandil
por: Tarkin, Jason M., et al.
Publicado: (2017)

Alterations in vasodilator-stimulated phosphoprotein (VASP) phosphorylation: associations with asthmatic phenotype, airway inflammation and β(2)-agonist use
por: Hastie, Annette T, et al.
Publicado: (2006)

Vasodilator-Stimulated Phosphoprotein (VASP)-dependent and -independent pathways regulate thrombin-induced activation of Rap1b in platelets
por: Benz, Peter M., et al.
Publicado: (2016)

Vasodilator-stimulated phosphoprotein (VASP) is not a major mediator of platelet aggregation, thrombogenesis, haemostasis, and antiplatelet effect of prasugrel in rats
por: Ito, Yusuke, et al.
Publicado: (2018)

Novel Dual Therapy: A Paradigm Shift in Anticoagulation in Patients of Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
por: Pradhan, Akshyaya, et al.
Publicado: (2020)

Percutaneous Nephrolithotomy in Patients on Chronic Anticoagulant/Antiplatelet Therapy
por: Nerli, R B, et al.
Publicado: (2012)

Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
por: ten Berg, Jurriën M, et al.
Publicado: (2001)

Deficiency of Vasodilator-Stimulated Phosphoprotein (VASP) Increases Blood-Brain-Barrier Damage and Edema Formation after Ischemic Stroke in Mice
por: Kraft, Peter, et al.
Publicado: (2010)

Nobiletin, a citrus flavonoid, activates vasodilator-stimulated phosphoprotein in human platelets through non-cyclic nucleotide-related mechanisms
por: Jayakumar, Thanasekaran, et al.
Publicado: (2017)

Nobiletin, a citrus flavonoid, activates vasodilator-stimulated phosphoprotein in human platelets through non-cyclic nucleotide-related mechanisms
por: Jayakumar, Thanasekaran, et al.
Publicado: (2020)

Physician's Fear of Anticoagulant Therapy in Nonvalvular Atrial Fibrillation
por: Sen, Souvik, et al.
Publicado: (2014)

Oral Anticoagulation and Antiarrhythmic Drug Therapy for Atrial Fibrillation
por: Reiffel, James A.
Publicado: (2018)

Atrial fibrillation, electroconvulsive therapy, stroke risk, and anticoagulation
por: Kapadia, Meera, et al.
Publicado: (2023)

Role of Vasodilator Therapy in Acute Heart Failure
por: Batool, Aisha, et al.
Publicado: (2021)

Percutaneous closure of the left atrial appendage for secondary prevention of stroke in patients with atrial fibrillation and contraindications to chronic anticoagulant therapy
por: Lasek-Bal, Anetta, et al.
Publicado: (2015)

Clinical Relevance of Anticoagulation and Dual Antiplatelet Therapy to the Outcomes of Patients With Atrial Fibrillation and Recent Percutaneous Coronary Intervention With Stent
por: De Vecchis, Renato, et al.
Publicado: (2016)

Percutaneous Left Atrial Appendage Closure in a Patient with Diffuse Alveolar Hemorrhaging Associated with Anticoagulant Therapy and Atrial Fibrillation
por: Ogoshi, Takaaki, et al.
Publicado: (2021)

Dual Roles of Quercetin in Platelets: Phosphoinositide-3-Kinase and MAP Kinases Inhibition, and cAMP-Dependent Vasodilator-Stimulated Phosphoprotein Stimulation
por: Oh, Won Jun, et al.
Publicado: (2012)

Vasodilator-stimulated phosphoprotein-phosphorylation by ginsenoside Ro inhibits fibrinogen binding to αIIb/β(3) in thrombin-induced human platelets
por: Shin, Jung-Hae, et al.
Publicado: (2016)

Critical Appraisal of Guidelines for Antithrombotic Therapy in Atrial Fibrillation Post-Percutaneous Coronary Intervention
por: Fan, Yongqiang, et al.
Publicado: (2022)

Can doubling the maintenance dose of clopidogrel prevent from early stent thrombosis after the primary percutaneous coronary intervention?
por: Roghani, Farshad, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_12tg9ugtn52fi812op937vvvor